An Exosomal microRNA Signature for Preoperative Staging in Colon Cancer
NCT07255729 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2025-12-01
Summary
Recent studies have highlighted the potential benefits of neoadjuvant chemotherapy (NAC) in colon cancer; however, its indication is generally limited to cases corresponding to pathological stage IIB or higher. Accurately identifying such high-risk cases before surgery remains challenging using conventional clinical diagnostics alone. Therefore, we hypothesized that integrating molecular biomarkers with preoperative clinical assessment could provide a more precise and sensitive evaluation of tumor aggressiveness. In this context, we focused on exosomal microRNAs, which are actively secreted from tumor cells and remain stable in circulation, and aimed to develop a machine learning-based biomarker panel. To achieve this, we initiated a multicenter study utilizing preoperative plasma samples to establish a reliable biomarker model for risk stratification and treatment decision-making in colon cancer.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Diagnostic Test: EXPOSE assay(Small RNA-seq of exosomal miRNAs)
Candidates identified from small RNA sequencing
- DIAGNOSTIC_TEST
-
Diagnostic Test: EXPOSE RT-qPCR panel
Quantification of exosomal microRNAs (RT-qPCR)
Sponsors & Collaborators
-
City of Hope Medical Center
lead OTHER
Principal Investigators
-
Ajay Goel, PhD · City of Hope Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-15
- Primary Completion
- 2026-06-18
- Completion
- 2026-06-18
Countries
- United States
Study Locations
More Related Trials
-
A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer
NCT06682247 ·Status: NOT_YET_RECRUITING
-
MRD-Guided Surveillance in Operable Colon Adenocarcinoma (I-III)(SURVEILLANCE-I)
NCT06879873 ·Status: NOT_YET_RECRUITING
-
Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer
NCT06904677 ·Status: RECRUITING
-
Metabolomics to Predict Treatment Response and Toxicities in Rectal Cancer
NCT06831669 ·Status: RECRUITING
-
Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology
NCT05969938 ·Status: UNKNOWN
-
Molecular Study and Precision Medicine for Colorectal Cancer
NCT05883683 ·Status: NOT_YET_RECRUITING
-
Regorafenib in Taiwan Metastatic Colorectal Cancer (mCRC) Patients
NCT03829852 ·Status: COMPLETED
-
Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer
NCT06557668 ·Status: RECRUITING
-
Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status
NCT06356714 ·Status: RECRUITING ·Phase: PHASE2
-
Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
NCT03573791 ·Status: RECRUITING
-
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
NCT03659448 ·Status: RECRUITING ·Phase: PHASE3
-
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer
NCT04428905 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Clinical Study of QSOX1 as a Biomarker for Colon Cancer
NCT05827471 ·Status: NOT_YET_RECRUITING
-
An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer
NCT05245786 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
EGFR-IL12-CART Cells for Patients With Metastatic Colorectal Cancer
NCT03542799 ·Status: UNKNOWN ·Phase: PHASE1
-
Microbiome and Rectal Cancer
NCT04223102 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
ctDNA-Informed Management of Early-Stage Rectal Cancer
NCT07209215 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Application Value of Spectral CT in the Accurate Staging of Colorectal Cancer
NCT06977373 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Exploring the Predictive Effect of Intestinal and Oral Microbiota on the Efficacy of Neoadjuvant Radiotherapy and Chemotherapy for Locally Advanced Rectal Cancer Based on Machine Learning
NCT07346729 ·Status: COMPLETED
-
Immunoscintigraphy Using Radiolabeled Monoclonal Antibody in Finding Tumor Cells in Patients With Colorectal Cancer
NCT00647153 ·Status: COMPLETED ·Phase: PHASE1
-
Organ Preservation Strategy of Total Neoadjuvant Chemoradiotherapy for Low Rectal Carcinoma
NCT05563922 ·Status: RECRUITING ·Phase: PHASE2
-
A Prospective Study of Expression Profiling-based Assessment of the Efficacy of Neoadjuvant Therapy for Rectal Cancer
NCT06746298 ·Status: NOT_YET_RECRUITING
-
Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer
NCT04466254 ·Status: UNKNOWN ·Phase: PHASE2
-
Effects of Exosome Adminstration in Preventing Early Leakage in Rectal Cancer Patients Undergoing Low Anterior Resection
NCT06536712 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients
NCT02022995 ·Status: COMPLETED